Implementation of biosafety norms not satisfactory: Gbedemah

 Funds availability a major hindrance, says head of biosafety at CBD

Funds a major constraint in implementing Cartagena Protocol

Parties to the protocol emphasise on need for capacity building for managing risks from genetically engineered products

Decision on capacity building to handle GMOs tops biosafety meet agenda

Countries have reported they lack appropriate legal, institutional and technical capacity for decision making on genetically modified organisms